MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1080/10428194.2025.2602050

Медицинская библиотека · Leukemia & lymphoma · 2025

Daratumumab bortezomib and dexamethasone in transplant ineligible newly diagnosed elderly myeloma patients (AMN006)-a trial by Asian Myeloma Network (NCT03695744).

Tan Melinda S Y, Nagarajan Chandramouli, Ooi Melissa, De Mel Sanjay, Binte Hashim Nur Shahidah, Li Xinhua, Chua Ashlett, Pokharkar Yogesh, Tso Allison, Awasthi Neha, Durie Brian, Chen Yunxin, Chng Wee Joo

СтатьяКлиническое исследование II фазыМногоцентровое исследованиеПеревод пока не подготовлен

Аннотация

AMN006 is a prospective, single-arm, phase 2 study evaluating the efficacy and safety of daratumumab, bortezomib, and dexamethasone (DVd) in elderly, transplant-ineligible (TI) patients with newly diagnosed multiple myeloma (NDMM). The primary end point was overall response rate (ORR); secondary endpoints included progression-free survival (PFS), overall survival (OS) and safety. 27 patients were enrolled between October 2019 and September 2021. Treatment comprised fixed-duration DVd (9 months) followed by daratumumab maintenance until progression or toxicity. At a median follow-up of 27 months, the ORR was 96.3%, ≥CR in 29.6% and VGPR in 51.9%. Among patients achieving ≥ CR, 7/8 were MRD-negative (sensitivity 10-5). Median PFS was 36.5 months; median OS was not reached. The regimen was well tolerated, with treatment-emergent adverse events related to study drugs in 22% of patients. These findings support the feasibility of time-limited DVd and daratumumab maintenance as an effective and tolerable frontline approach for TI NDMM patients. Trial Registration: NCT03695744.

Для цитирования: Tan Melinda S Y, Nagarajan Chandramouli, Ooi Melissa, De Mel Sanjay, Binte Hashim Nur Shahidah, Li Xinhua, Chua Ashlett, Pokharkar Yogesh, Tso Allison, Awasthi Neha, Durie Brian, Chen Yunxin, Chng Wee Joo. Daratumumab bortezomib and dexamethasone in transplant ineligible newly diagnosed elderly myeloma patients (AMN006)-a trial by Asian Myeloma Network (NCT03695744).. Leukemia & lymphoma. 2025. DOI: 10.1080/10428194.2025.2602050.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.